Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
NOTA:FRA
ნოვარტისი
121,00 €
0,00%
(0,00) 1D
30 აპრ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NOTA...
Open
121,00 €
High
121,00 €
Low
121,00 €
Mkt. cap
295,57 მლრ.
Avg. vol.
16,00
Volume
0,00
52-wk high
145,00 €
52-wk low
93,00 €
No. of employees
75 ათ.
News stories
From sources across the web
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About ნოვარტისი
CEOვასანტ ნარასიმჰანი
Employees75,3 ათ.
Founded29 თებ. 1996
Headquartersბაზელი, ბაზელ-შტადტის კანტონი, შვეიცარია
SectorPharmaceutical industry
Websitenovartis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
14,84 მლრდ.
14,36 მლრდ.
13,86 მლრდ.
13,52 მლრდ.
Cost of goods sold
3,32 მლრდ.
3,54 მლრდ.
3,54 მლრდ.
3,44 მლრდ.
Cost of revenue
3,32 მლრდ.
3,54 მლრდ.
3,54 მლრდ.
3,44 მლრდ.
Research and development expenses
2,62 მლრდ.
2,86 მლრდ.
2,84 მლრდ.
2,78 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,44 მლრდ.
3,30 მლრდ.
3,44 მლრდ.
3,14 მლრდ.
Operating expense
6,05 მლრდ.
6,24 მლრდ.
6,46 მლრდ.
5,96 მლრდ.
Total operating expenses
9,37 მლრდ.
9,77 მლრდ.
10,00 მლრდ.
9,40 მლრდ.
Operating income
5,46 მლრდ.
4,58 მლრდ.
3,86 მლრდ.
4,12 მლრდ.
Other non operating income
-13,00 მლნ.
-7,00 მლნ.
-130,00 მლნ.
4,00 მლნ.
EBT including unusual items
4,53 მლრდ.
4,20 მლრდ.
3,22 მლრდ.
3,84 მლრდ.
EBT excluding unusual items
5,16 მლრდ.
4,29 მლრდ.
3,49 მლრდ.
3,78 მლრდ.
Income tax expense
507,00 მლნ.
266,00 მლნ.
814,00 მლნ.
683,00 მლნ.
Effective tax rate
11,19%
6,34%
25,30%
17,79%
Other operating expenses
-4,00 მლნ.
70,00 მლნ.
190,00 მლნ.
42,00 მლნ.
Net income
4,04 მლრდ.
3,93 მლრდ.
2,41 მლრდ.
3,16 მლრდ.
Net profit margin
27,24%
27,36%
17,38%
23,34%
Earnings per share
2,42
2,25
2,03
1,99
Interest and investment income
-
-
373,00 მლნ.
-
Interest expense
-289,00 მლნ.
-281,00 მლნ.
-304,00 მლნ.
-343,00 მლნ.
Net interest expenses
-289,00 მლნ.
-281,00 მლნ.
69,00 მლნ.
-343,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
6,56 მლრდ.
5,78 მლრდ.
4,96 მლრდ.
5,24 მლრდ.
Gain or loss from assets sale
-67,00 მლნ.
81,00 მლნ.
80,00 მლნ.
-159,00 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer